Trial no.:
|
PACTR201709002509200 |
Date of Approval:
|
09/08/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
A Randomized Controlled Trial of Sequential Versus Simultaneous Use of Foley Balloon and oxytocin for Induction of Labor in Nulliparous pregnant women |
Official scientific title |
A Randomized Controlled Trial of Sequential Versus Simultaneous Use of Foley Balloon and oxytocin for Induction of Labor in Nulliparous pregnant women |
Brief summary describing the background
and objectives of the trial
|
Pre-induction cervical ripening with the trans-cervical Foley balloon is a proven, safe and effective method. There is paucity of literature regarding the timing of initiation of oxytocin following insertion of Foley catheter. Oxytocin may be started simultaneous to the Foley catheter or sequentially after the Foley catheter is expelled. The sequential method is used in our set up but studies have shown that the simultaneous method shortens the induction to delivery time without increasing the cesarean section rate. This study is going to be conducted with an objective of determining whether the induction of labor with simultaneous use of oxytocin and Foley balloon decreases the time to delivery in nulliparous women as compared to sequential use of Foley balloon followed by oxytocin.
A randomized clinical trial of nulliparous women presenting for induction of labor at Saint Paul¿s Hospital will be conducted to determine whether simultaneous versus sequential use of Foley balloon with oxytocin decreases induction to delivery time. A total of 140 women will be recruited and 70 will be started on simultaneous trans-cervical Foley balloon insertion with oxytocin while the rest 70 will be started on sequential oxytocin after Foley catheter is expelled or was put in place for 12 hours whichever comes first. The primary outcome will be the induction to delivery time. Secondary outcomes included are cesarean delivery rate, rates of chorioamnionitis, estimated blood loss, rates of postpartum hemorrhage and a composite neonatal outcome. An intention-to-treat (ITT) analyses will be performed. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Maternal health - Induction of labor,Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
18/09/2017 |
Actual trial start date |
12/11/1919 |
Anticipated date of last follow up |
11/05/2020 |
Actual Last follow-up date |
11/05/2020 |
Anticipated target sample size (number of participants) |
140 |
Actual target sample size (number of participants) |
140 |
Recruitment status |
Recruiting |
Publication URL |
|
|